Thus, our findings suggest that neither UPR hyperactivation (during infection) nor hypoactivation (after IRE1 inhibition) alone fully explains keratinocyte migration; rather, both extremes of UPR activity are implicated. The gene discussed is ERN1; the disease is infection.